Literature DB >> 6851315

Charnley low-friction arthroplasty in patients with psoriasis.

T J Menon, B M Wroblewski.   

Abstract

A retrospective study of 38 patients with established psoriasis treated by 55 Charnley low-friction arthroplasties showed a superficial infection rate of 9.1% and a deep infection rate of 5.5%. All of the operations were carried out in the Charnley clean-air enclosure, without prophylactic antibiotic therapy. The incidence of postoperative sepsis in psoriatic patients was significantly higher than in patients with osteoarthritis (p less than 0.001) and rheumatoid arthritis (p less than 0.05). Hence, prophylactic antibiotic therapy appears beneficial in psoriatic patients.

Entities:  

Mesh:

Year:  1983        PMID: 6851315

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  Psoriasis is a risk factor for hip-prosthesis infection.

Authors:  M Drancourt; J N Argenson; H Tissot Dupont; J M Aubaniac; D Raoult
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

2.  Periprosthetic joint infection in patients with inflammatory joint disease: a review of risk factors and current approaches to diagnosis and management.

Authors:  Todd A Morrison; Mark Figgie; Andy O Miller; Susan M Goodman
Journal:  HSS J       Date:  2013-07-03

3.  Wound healing in a patient with psoriasis vulgaris and femur megaprosthesis implantation.

Authors:  Markus Nottrott; Jendrik Hardes; Winfried Winkelmann; Georg Gosheger
Journal:  Sarcoma       Date:  2008

Review 4.  National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Authors:  Alexa B Kimball; Dafna Gladman; Joel M Gelfand; Kenneth Gordon; Elizabeth J Horn; Neil J Korman; Gretchen Korver; Gerald G Krueger; Bruce E Strober; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2008-03-04       Impact factor: 11.527

Review 5.  Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: Prevention and Diagnosis.

Authors:  Ajay Premkumar; Kyle Morse; Ashley E Levack; Mathias P Bostrom; Alberto V Carli
Journal:  Curr Rheumatol Rep       Date:  2018-09-10       Impact factor: 4.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.